Literature DB >> 23139

beta-Adrenoceptor antagonists and respiratory function.

D G McDevitt.   

Abstract

Mesh:

Substances:

Year:  1978        PMID: 23139      PMCID: PMC1429241          DOI: 10.1111/j.1365-2125.1978.tb01607.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  18 in total

1.  EFFECT OF A BETA-ADRENERGIC-BLOCKING AGENT, PROPRANOLOL, ON ASTHMATICS.

Authors:  R S MCNEILL
Journal:  Lancet       Date:  1964-11-21       Impact factor: 79.321

2.  Effect of propranolol on respiratory function and exercise tolerance in patients with chronic obstructive lung disease.

Authors:  L A Nordstrom; F MacDonald; F L Gobel
Journal:  Chest       Date:  1975-03       Impact factor: 9.410

Review 3.  The assessment of beta-adrenoceptor blocking drugs in man.

Authors:  D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

4.  Studies of cardioselectivity and partial agonist activity in beta-adrenoceptor blockade comparing effects on heart rate and peak expiratory flow rate during exercise.

Authors:  V M Oh; C M Kaye; S J Warrington; E A Taylor; J Wadsworth
Journal:  Br J Clin Pharmacol       Date:  1978-02       Impact factor: 4.335

5.  Selective blockade of adrenoceptive beta receptors in the heart.

Authors:  D Dunlop; R G Shanks
Journal:  Br J Pharmacol Chemother       Date:  1968-01

6.  Use of practolol in asthmatics: a plea for caution.

Authors:  L C Chang
Journal:  Lancet       Date:  1971-08-07       Impact factor: 79.321

7.  Practolol treatment in asthmatics.

Authors:  H J Waal-Manning; F O Simpson
Journal:  Lancet       Date:  1971-12-04       Impact factor: 79.321

8.  Effects of intravenous propranolol and metoprolol and their interaction with isoprenaline on pulmonary function, heart rate and blood pressure in asthmatics.

Authors:  G Johnsson; N Svedmyr; G Thiringer
Journal:  Eur J Clin Pharmacol       Date:  1975-04-04       Impact factor: 2.953

9.  Selective beta-1 receptor blockade with oral practolol in man. A dose-related phenomenon.

Authors:  J J Lertora; A L Mark; J Johannsen; W R Wilson; F M Abboud
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

10.  Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction.

Authors:  W H Perks; S S Chatterjee; R S Croxson; J M Cruickshank
Journal:  Br J Clin Pharmacol       Date:  1978-02       Impact factor: 4.335

View more
  17 in total

1.  Beta-adrenoceptor antagonists and respiratory function.

Authors:  W H Perks; S S Chatterjee; R S Croxson; J M Cruickshank
Journal:  Br J Clin Pharmacol       Date:  1978-08       Impact factor: 4.335

2.  Beta-adrenoceptor antagonists and respiratory function.

Authors:  V M Oh; C M Kaye; S J Warrington; E A Taylor; J Wadsworth
Journal:  Br J Clin Pharmacol       Date:  1978-08       Impact factor: 4.335

3.  Adrenoceptor blocking drugs: clinical pharmacology and therapeutic use.

Authors:  D G McDevitt
Journal:  Drugs       Date:  1979-04       Impact factor: 9.546

4.  Exercise responses of healthy subjects in the evaluation of cardioselectivity of beta-blockers.

Authors:  K L Woods; S P Linton; M J Kendall; E B Faragher; R J Grieve
Journal:  Eur J Clin Pharmacol       Date:  1979-05-21       Impact factor: 2.953

5.  Time course of the bronchial response to salbutamol after placebo, betaxolol and propranolol.

Authors:  R Palminteri; G Kaik
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  The effects of pafenolol and metoprolol on ventilatory function and haemodynamics during exercise by asthmatic patients.

Authors:  C G Löfdahl; G E Marlin; N Svedmyr
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Partial agonist activity of practolol on human lymphocyte cyclic AMP production.

Authors:  D R Lima; P Turner
Journal:  Br J Clin Pharmacol       Date:  1981-05       Impact factor: 4.335

8.  Quantitative assessment of bronchial beta-adrenoceptor blockade in man.

Authors:  H R Gribbin; C J Baldwin; A E Tattersfield
Journal:  Br J Clin Pharmacol       Date:  1979-06       Impact factor: 4.335

9.  Assessment of beta-adrenoceptor antagonists in asthmatic patients.

Authors:  R E Ruffin; E L McIntyre; K M Latimer; H E Ward; A J Crockett; J H Alpers
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

10.  Influence of environmental temperature and humidity on bronchial responses during assessment of selectivity of beta-adrenoceptor antagonists in man.

Authors:  E A Taylor; P W Trembath; S J Warrington
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.